Načítá se...
TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2
Introduction: The COVID-19 pandemic remains aglobal challenge. While there are mRNA agents on the horizon as apotential prevention, adefinitive drug therapy is an unmet medical need. The hyperinflammatory response, known as the ‘cytokine storm’, is chiefly responsible for complications and deaths. T...
Uloženo v:
| Vydáno v: | Expert Opin Ther Targets |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8095161/ https://ncbi.nlm.nih.gov/pubmed/33857397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728222.2021.1918103 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|